Search
for
Sort by
Research 61–90 of 1000+
- Management OF Patients with Polycystic Ovary Syndrom
- What should be kept in mind when treating acne with oral contraceptives? Narrative review
- Review on Diagnostic and Managerial Consequences of PCOS Among Females
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- Das polyzystische Ovarsyndrom: Aktuelle Evidenz und praktische Empfehlungen
- Polycystic ovarian syndrome
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- Polycystic Ovary Syndrome
- Obesity and the Polycystic Ovary Syndrome
- Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
- The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study
- Female Adolescent Hair Disorders
- Hyperandrogenism in Adolescent Girls
- Healthy Skin for Women: A Review of Common Conditions and Therapies
- Pharmacological Treatment of Alopecia
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- An Overview of Harmful Effects of Polycystic Ovary Syndrome
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- SAT383 Case Study: Impact of Weight Reduction and Oral Contraceptive Pills on Hyperandrogenism
- Knowledge and beliefs about the use/abuse of oral contraceptive pills among males: A mixed-method explanatory sequential study in community pharmacy settings
- The treatment of polycystic ovary syndrome.
- Correction of meta-analysis after retraction of article on the effects of anti-androgens in polycystic ovary syndrome
- The interplay of oxidative stress and immune dysfunction in Hashimoto’s thyroiditis and polycystic ovary syndrome: a comprehensive review
- Hirsutism
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- Pharmacotherapy of polycystic ovary syndrome - an update
- Melasma and other skin manifestations or oral contraceptives.
- SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
- This Month in Archives of Dermatology
- [Systematic treatment with sex hormones in dermatology].